We have located links that may give you full text access.
Influenza vaccination in mitigating vascular events and risk.
Current Opinion in Cardiology 2022 December 30
PURPOSE OF REVIEW: Influenza imparts a significant health burden on the United States and global population. Furthermore, influenza is associated with acute cardiovascular events, including heart failure exacerbations, acute coronary syndromes, strokes, and overall cardiovascular mortality. We review the role of seasonal influenza vaccination in mitigating cardiovascular risk.
RECENT FINDINGS: A large study assessed the impact of influenza vaccine on cardiovascular outcomes and mortality using the US National Inpatient Sample (NIS) database. This study included 22 634 643 hospitalizations. Vaccination against influenza was associated with a reduction in myocardial infarctions (MI) [relative risk (RR) = 0.84, 95% CI 0.82-0.87, P < 0.001], transient ischemic attacks (RR = 0.93, 95% CI 0.9-0.96, P < 0.001), cardiac arrests (RR = 0.36, 95% CI 0.33-0.39, P < 0.001), strokes (RR = 0.94, 95% CI 0.91-0.97, P < 0.001), and overall mortality (RR = 0.38, 95% CI 0.36-0.4, P < 0.001).
SUMMARY: Available data suggests that seasonal influenza vaccination is very effective in mitigating cardiovascular risk. Increasing the rates of influenza vaccination, especially among those with cardiovascular risk factors, is critical in preventing infection and attenuating influenza-related cardiovascular complications and adverse outcomes.
RECENT FINDINGS: A large study assessed the impact of influenza vaccine on cardiovascular outcomes and mortality using the US National Inpatient Sample (NIS) database. This study included 22 634 643 hospitalizations. Vaccination against influenza was associated with a reduction in myocardial infarctions (MI) [relative risk (RR) = 0.84, 95% CI 0.82-0.87, P < 0.001], transient ischemic attacks (RR = 0.93, 95% CI 0.9-0.96, P < 0.001), cardiac arrests (RR = 0.36, 95% CI 0.33-0.39, P < 0.001), strokes (RR = 0.94, 95% CI 0.91-0.97, P < 0.001), and overall mortality (RR = 0.38, 95% CI 0.36-0.4, P < 0.001).
SUMMARY: Available data suggests that seasonal influenza vaccination is very effective in mitigating cardiovascular risk. Increasing the rates of influenza vaccination, especially among those with cardiovascular risk factors, is critical in preventing infection and attenuating influenza-related cardiovascular complications and adverse outcomes.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app